| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $6.7M | -75.2% |
| Cost of Revenue | $6.0M | -76.8% |
| Gross Profit | $762K | -46.8% |
| R&D Expense | $57K | -78.8% |
| SG&A Expense | $7.3M | -18.9% |
| Operating Income | -$6.7M | +24.0% |
| Interest Expense | $71K | -85.8% |
| Pre-tax Income | -$7.5M | +64.2% |
| Income Tax | $35K |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Accounts Receivable | $2.0M | -35.4% |
| Inventory | $852K | -56.4% |
| Current Assets | $7.2M | -42.5% |
| Total Assets | $25.4M | -40.4% |
| Current Liabilities | $13.3M | -30.6% |
| Long-term Debt | $411K | -89.2% |
| Total Liabilities | $13.7M | -40.8% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $929K | +117.6% |
| Capital Expenditures | $8K | -92.3% |
| Investing Cash Flow | -$5K | -100.2% |
| Financing Cash Flow | -$972K | -133.7% |
| Free Cash Flow | $921K | +117.1% |
| +0.0% |
| Net Income | -$7.3M | +64.8% |
| Stockholders' Equity |
| $11.7M |
| -39.8% |